SNBL CPC, Inc. is a 96-bed, state of the art, Phase I/IIa Clinical Pharmacology Center focused on supporting complex, multi-faceted, early stage Clinical Development programs. We manage complexity by employing the best-in-class facility, technology and operational excellence necessary to ensure the integrity of each trial. We partner with pharmaceutical companies to accelerate product development and to help expedite marketability.

SNBL was founded in 1957 as Japan's first contract research organization (CRO). It immediately gained recognition for its preclinical research. SNBL, now recognized as Japan's foremost CRO and worlds leading nonhuman primate (NHP) research organization, has evolved into an international full-service CRO with facilities, offices and subsidiaries in the U.S., Europe, and China.

Core Competency

Design, Conduct Phase I/IIa Clinical Trials

• First-in-human
• Dose Escalation
• Bioavailability/Bioequivalence
• PK/PD
• Food Effect
• QT/QTc
• Vaccine Development
• Radiolabel - Mass Balance

Secondary (through other SNBL Group companies)

• Pharmacokinetic/Pharmacodynamic Analysis
• Pharmacokinetics and Bioanalysis Center (Wakayama, Japan)
• Central Cardiology lab capabilities
• Data Management/Statistical Analysis

96 bed Inpatient facility

48 beds with Intensive Care-level bedside monitoring

40 VS1 machines

• Blood Pressure
• Temperature
• Pulse
• Pulse Oximetry

Phillips ECG (12 Lead) machines
ECG Telemetry Transmitters
Phillips Heart Monitors
B Braun Intravenous Pumps
Bedside Oxygen
Crash Cart/Defibrillator

Separate Outpatient Facility

5 Examination Rooms
2 Phlebotomy Rooms

Technology

Initiator Clinical Information System
ECG Digital Management System
QTc Measurement and Analysis Software
Access Control (Security)
Comprehensive Environmental Monitoring

Mohamed S. Al-Ibrahim, M.D., FACP – COO & President

Board Certification:

• Internal Medicine
• Infectious Diseases

Executive Positions:

• Chief Medical Officer, Maryland General Hospital, Baltimore
• Executive Chief of Staff, VA Maryland Health Care System
• Professor of Medicine & Associate Dean, University of Maryland, School of Medicine

Military Service:

• Colonel, Medical Corps, USAR

Major Research Interests:

• Adult Vaccine Development (Pneumococcal, Influenza, Pertussis)
• Antibiotic Development Trials (Cefuroxime, Sparfloxacin, Levofloxacin, Clinafloxacin)

Stephan A. Bart, M.D., CPI - Chief Medical Officer

Board Certification:

• American Board of Family Practice
• American Board of Medical Examiners
• Certified Physician Investigator

Executive Positions:

• Medical Director of Clinical Research, Blair Medical Associates
• Medical Director of Urgent Care, Blair Medical Associates
• Medical Director of Clinical Research, Radiant Research
• President, Stephan A Bart SR MD PA
• President, American Family Practice Associates

Major Research Interests:

• Numerous Clinical Trials Experience (Phase I-IV) demonstrating leadership, management skills, and ability of interfacing with researchers, sponsors and regulatory officials.
• Serves as Safety Review Committee Board Member for Major Pharmaceutical Clinical Trials
• Serves as Coordinating Investigator for Major Pharma multi-site, multi national Studies
• Broad Therapeutic Indications

Masaru Kaneko, M.D. - Senior Research Physician

Board Certification:

• American Board of Psychiatry and Neurology
• Japanese Society of Neurology
• Japanese Society of Internal Medicine

Executive Positions:

• Vice-Director, Matsudo Neurology Clinic, Japan

Clinical Positions:

• Staff Neurologist, Chiba University Hospital, Japan
• Staff Neurologist, Nakaizu Rehabilitation center, Japan

Major Research Interests:

• Neuropathy
• Epilepsy
• Neuromuscular Diseases
• Aphasia

Donald Pritchard, MD - Research Physician

Board Certification:

• American Board of Internal Medicine
• American Board of Medical Examiners
• Geriatric Certification

Executive Positions:

• Principal Investigator, Covance Clinical Research Unit, Florida
• Physician - Internal Medicine
• Physician - Internal Medicine, Crystal River Primary Care, Florida

Major Research Interests:

• Broad Therapeutic Indications
• Phase I - Phase IV experience

Cheryl M. Duggan, C.C.T - Director of Clinical Operations

Executive Positions:

• Site Director - Phase I-IV, Radiant Research, Inc., GA & FL
• Director of Clinical Operations-Phase I, Peninsular Testing Corporation
• Associate Director - Phase I unit, Clinical Studies LTD, Florida

Major Research Expertise:

• 15 yrs experience in conducting Phase I trials.
• Coordinated more than 200 trials.
• The development, implementation, monitoring and support of Standard Operating Procedures and clinical work processes.
• Resource Allocation

Professional Affiliations:

• Association of Clinical Research Professionals

Contact Information

SNBL Clinical Pharmacology Center, Inc.
Business Development
800 West Baltimore St.
Baltimore, MD 21201 USA
Phone: 410-706-8877
Fax: 410-706-8963
E-mail:

If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:
	Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.